SOW
RAPP

State of Wyoming’s Rapport Therapeutics RAPP Stock Holding History

State of Wyoming’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65K Buy
+1,560
New +$57.3K 0.01% 1618

Other funds holding RAPP

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

State of Wyoming's RAPP Position: Q2 2026 in Review

State of Wyoming opened a new position in Rapport Therapeutics (RAPP) in Q2 2026: 1,560 shares worth $65K. The stake represents 0.01% of the portfolio and ranks #1618 among its holdings.

38 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • State of Wyoming held 1,560 shares of Rapport Therapeutics worth $65K as of Q2 2026.
  • Rapport Therapeutics was a new State of Wyoming position in Q2 2026.
  • Rapport Therapeutics made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1618 holding.
  • 38 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.